| Dr Tommy Alan Brown Ii, MD | |
|
3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 | |
| (210) 916-3400 | |
| Not Available |
| Full Name | Dr Tommy Alan Brown Ii |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 3551 Roger Brooke Dr, Fort Sam Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043637523 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | U6547 (Texas) | Secondary |
| 2086S0102X | Surgery - Surgical Critical Care | U6547 (Texas) | Secondary |
| 2086S0127X | Surgery - Trauma Surgery | U6547 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tommy Alan Brown Ii, MD 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (210) 916-3400 | Dr Tommy Alan Brown Ii, MD 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (210) 916-3400 |
News Archive
Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.
McMaster scientists are very close to defining small molecule drugs that should be able to redirect the huntingtin protein from accumulating in the wrong place within brain cells, which could potentially translate to a therapy for Huntington's Disease (HD).
Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the "Units"), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.
"A nationwide conditional cash transfer program in the Philippines is slowly improving maternal health, but more is needed to reverse the climbing maternal mortality ratio, say women's groups," IRIN reports.
Human error, not human biology, largely accounts for the apparent decline of mortality among the very old, according to a new report publishing on December 20 in the open-access journal PLOS Biology by Saul Newman of Australia National University in Canberra.
› Verified 6 days ago
Dr. George Earl Peoples Jr., M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4235 Fax: 210-916-5102 | |
Dr. Jeremy Tyler Bolin, MD Surgery Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 | |
Dr. John Christopher Graybill, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr Dept Of, Attention Program Coordinator, Fort Sam Houston, TX 78234 Phone: 210-916-5371 | |
Dr. Jordan Lane Guice, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 | |
Dr. Pamela Christine Masella, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-0393 | |
Dr. Jamie Rand, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-539-9582 |